Czech Republic - Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis
Since 2014, Czech Republic Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis fell by 1.4points year on year. In 2019, the country was ranked number 278 among other countries in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis with 40 Percent. Norway topped the ranking with 108 Percent in 2019, that is +2.9points versus 2018. Austria, Burundi and Marshall Islands respectively ranked number 2, 3 and 4 in this ranking. Equatorial Guinea witnessed the best average annual growth at +34.3points per year, while United Arab Emirates recorded the worst performance at -100points per year.
Loading...
Date | Percent |
---|---|
2019 | 40.00 |
2018 | 40.00 |
2017 | 40.00 |
2016 | 39.00 |
2015 | 38.00 |
Download all data from 2007 to 2019
How does Czech Republic rank in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis?
# | 313 Countries | Percent | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Norway
|
108.00 % | 2019 | +2.9 % | +3.7 % | View data | |
2 |
#2
Austria
|
107.00 % | 2019 | +4.9 % | +11.2 % | View data | |
277 |
#277
Spain
|
41.00 % | 2015 | NA | NA | View data | |
278 |
#278
Czech Republic
|
40.00 % | 2019 | +0.0 % | -1.4 % | View data | |
278 |
#278
Guyana
|
40.00 % | 2015 | NA | +14.9 % | View data |